Figure 4From: Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodiesWhole-body changes in response to anti-VEGF treatment. Concentration profiles following a single intravenous injection of 10 mg/kg anti-VEGF given at time 0. A, VEGF concentration. B, Anti-VEGF concentration. C, Concentration of the VEGF/anti-VEGF complex.Back to article page